ProQR Therapeutics
PRQR
PRQR
55 hedge funds and large institutions have $47.5M invested in ProQR Therapeutics in 2023 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 18 increasing their positions, 4 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
21% less capital invested
Capital invested by funds: $60M → $47.5M (-$12.4M)
26% less call options, than puts
Call options by funds: $705K | Put options by funds: $950K
Holders
55
Holding in Top 10
2
Calls
$705K
Puts
$950K
Top Buyers
| 1 | +$6.18M | |
| 2 | +$2.39M | |
| 3 | +$2M | |
| 4 |
Morgan Stanley
New York
|
+$576K |
| 5 |
JPMorgan Chase & Co
New York
|
+$470K |
Top Sellers
| 1 | -$1.72M | |
| 2 | -$617K | |
| 3 | -$610K | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$381K |
| 5 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$359K |